Colon Microbes Provide Clues to Favorable Treatment Options in a Subset of Colon Cancer Patients - OncLive
6/16/2022 12:00:00 AM2 years 10 months ago
by Rutgers Cancer Institute of New Jersey
by Rutgers Cancer Institute of New Jersey
Investigators from Rutgers Cancer Institute of New Jersey, New Jersey’s only National Cancer Institute-Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of druggable oncogenic fusions in colon cancer specimens including…
Investigators from Rutgers Cancer Institute of New Jersey, New Jerseys only National Cancer Institute-Designated Comprehensive Cancer Center, led a collaborative study to examine the patterns of drug… [+3398 chars]
full article...